angiogeneseremmer	antineoplastisch middel	monoklonaal antilichaam	vasculaire-endotheliale-groeifactorreceptorantagonist
\|	\|	\|	\|

bevacizumab (substantie)
	bevacizumab
	Bevacizumab

Id	409406007
Status	Primitive

Has disposition	angiogeneseremmer
Has disposition	Vascular endothelial growth factor receptor antagonist